ARTA
CDMO

A.R.T. Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

A.R.T. Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-34,306
Closed -$263K – 1056
2019
Q4 		$263K Buy
+34,306
New +$200K 0.01% 1070
2019
Q3 		– Sell
-18,506
Closed -$104K – 1780
2019
Q2 		$104K Sell
18,506
-19,100
-51% -$78.7K 0.01% 1189
2019
Q1 		$160K Buy
37,606
+6,867
+22% +$28K 0.01% 1109
2018
Q4 		$126K Buy
30,739
+7,742
+34% +$40.4K 0.01% 1134
2018
Q3 		$157K Sell
22,997
-22,059
-49% -$131K 0.01% 1232
2018
Q2 		$176K Buy
45,056
+16,101
+56% +$55.9K 0.01% 1252
2018
Q1 		$84K Buy
+28,955
New +$89.5K ﹤0.01% 1369
2017
Q4 		– Sell
-44,766
Closed -$140K – 1722
2017
Q3 		$140K Buy
+44,766
New +$168K 0.01% 1185

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

A.R.T. Advisors's CDMO Position: Q1 2020 in Review

A.R.T. Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2020, closing a stake of 34,306 shares — an estimated $263K sold.

A.R.T. Advisors first reported a position in CDMO in Q3 2017 and held it in 8 quarters. The position peaked at $263K in Q4 2019. 98 funds tracked by Wall St. Rank hold CDMO as of Q1 2020.

  • A.R.T. Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 34,306 Avid Bioservices, Inc. Common Stock shares in Q1 2020, an estimated $263K.
  • A.R.T. Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2017 and held it in 8 quarters.
  • A.R.T. Advisors's Avid Bioservices, Inc. Common Stock position peaked at $263K in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.